Claude Dagenais

1.8k total citations
11 papers, 1.5k citations indexed

About

Claude Dagenais is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Claude Dagenais has authored 11 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pediatrics, Perinatology and Child Health and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Claude Dagenais's work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Barrier Structure and Function Studies (2 papers). Claude Dagenais is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Barrier Structure and Function Studies (2 papers). Claude Dagenais collaborates with scholars based in Canada, United States and France. Claude Dagenais's co-authors include Gary M. Pollack, Candace Graff, Christophe Rousselle, Jean‐Michel Scherrmann, Richard Béliveau, Michel Demeule, Julie Jodoin, Paul J. Ciaccio, Jenny McKay and Barry Greenberg and has published in prestigious journals such as Journal of Neurochemistry, Biochemical Pharmacology and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Claude Dagenais

11 papers receiving 1.4k citations

Peers

Countries citing papers authored by Claude Dagenais

Since Specialization

Citations

This map shows the geographic impact of Claude Dagenais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Dagenais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Dagenais more than expected).

Fields of papers citing papers by Claude Dagenais

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Dagenais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Dagenais. The network helps show where Claude Dagenais may publish in the future.

Co-authorship network of co-authors of Claude Dagenais

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Dagenais. A scholar is included among the top collaborators of Claude Dagenais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Dagenais. Claude Dagenais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	P-glycoprotein deficient mouse in situ blood–brain barrier permeability and its prediction using an in combo PAMPA model 2009 ·European Journal of Pharmaceutical Sciences ·Claude Dagenais, Alex Avdeef, Oksana Tsinman, (unknown), Richard Béliveau	53
2	Modulation of Notch Processing by γ-Secretase Inhibitors Causes Intestinal Goblet Cell Metaplasia and Induction of Genes Known to Specify Gut Secretory Lineage Differentiation 2004 ·Toxicological Sciences ·Joseph Milano, Jenny McKay, Claude Dagenais, (unknown), François Pognan, R.A. Gadient, Robert T. Jacobs, Anna Zacco, Barry Greenberg, Paul J. Ciaccio	432
3	Variable modulation of opioid brain uptake by P-glycoprotein in mice 2003 ·Biochemical Pharmacology ·Claude Dagenais, Candace Graff, Gary M. Pollack	185
4	High transcytosis of melanotransferrin (P97) across the blood–brain barrier 2002 ·Journal of Neurochemistry ·Michel Demeule, Julie Poirier, Julie Jodoin, Yanick Bertrand, Richard R. Desrosiers, Claude Dagenais, Tran Nguyen, (unknown), Reinhard Gabathuler, Malcolm L. Kennard, (unknown), Delara Karkan, (unknown), Laurence Fénart, Roméo Cecchelli, Richard Béliveau	177
5	Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood–brain barrier 2002 ·Vascular Pharmacology ·Michel Demeule, Anthony Régina, Julie Jodoin, Alain Laplante, Claude Dagenais, France Berthelet, Albert Moghrabi, Richard Béliveau	169
6	Interaction of Nonpeptidic δ Agonists with P‐Glycoprotein by In Situ Mouse Brain Perfusion: Liquid Chromatography–Mass Spectrometry Analysis and Internal Standard Strategy 2002 ·Journal of Pharmaceutical Sciences ·Claude Dagenais, Julie Ducharme, Gary M. Pollack	7
7	Multidrug Resistance in Brain Tumors: Roles of the Blood–brain Barrier 2001 ·Cancer and Metastasis Reviews ·Anthony Régina, Michel Demeule, Alain Laplante, Julie Jodoin, Claude Dagenais, France Berthelet, Albert Moghrabi, Richard Béliveau	103
8	Uptake and efflux of the peptidic delta-opioid receptor agonist [D-penicillamine2,5]-enkephalin at the murine blood–brain barrier by in situ perfusion 2001 ·Neuroscience Letters ·Claude Dagenais, Julie Ducharme, (unknown)	56
9	Effect of mdr1a P-Glycoprotein Gene Disruption, Gender, and Substrate Concentration on Brain Uptake of Selected Compounds 2001 ·Pharmaceutical Research ·Claude Dagenais, Jian Zong, Julie Ducharme, Gary M. Pollack	59
10	Screening of Multidrug-Resistance Sensitive Drugs by In Situ Brain Perfusion in P-Glycoprotein-Deficient Mice 2001 ·Pharmaceutical Research ·Salvatore Cisternino, Christophe Rousselle, Claude Dagenais, Jean‐Michel Scherrmann	60
11	Development of an In Situ Mouse Brain Perfusion Model and its Application to mdr1a P-Glycoprotein-Deficient Mice 2000 ·Journal of Cerebral Blood Flow & Metabolism ·Claude Dagenais, Christophe Rousselle, Gary M. Pollack, Jean‐Michel Scherrmann	162

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact